SCHEMBL4895643

SCHEMBL4895643

CCN(c1ccc(-c2ccc(C(F)(F)F)cc2)cc1)S(=O)(=O)c1cc(C)c(C)c(C(=O)OC)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 3/20 0.53
NPSR1 Q6W5P4 2/20 0.48
HDAC3 O15379 2/20 0.48
HDAC11 Q96DB2 2/20 0.48
HDAC6 Q9UBN7 2/20 0.48
POLB P06746 1/20 0.47
MAPK1 P28482 1/20 0.44
MAPT P10636 1/20 0.44
RORC P51449 3/20 0.43
NR1I2 O75469 1/20 0.43
RORA P35398 1/20 0.43
NR1H2 P55055 1/20 0.43
NR1H3 Q13133 1/20 0.43
RORB Q92753 1/20 0.43
NR1H4 Q96RI1 1/20 0.43
HSD11B1 P28845 1/20 0.42
PPARG P37231 1/20 0.41
PPARD Q03181 1/20 0.41
PPARA Q07869 1/20 0.41
TP53 P04637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4906417 0.92 HDAC8 (0.52) HDAC8NPSR1HDAC3HDAC11HDAC6
SCHEMBL4903639 0.89 HCRTR2 (0.50) HDAC8NPSR1HDAC3HDAC11HDAC6
SCHEMBL4894519 0.89 HDAC8 (0.52) HDAC8NPSR1HDAC3HDAC11HDAC6
SCHEMBL4897635 0.89 HDAC8 (0.53) HDAC8NPSR1HDAC3HDAC11HDAC6
SCHEMBL4894413 0.88 MMP2 (0.49) HDAC8NPSR1HDAC3HDAC11HDAC6
SCHEMBL4905740 0.84 ESR1 (0.56) HDAC8NPSR1POLBMAPTTP53
SCHEMBL4904184 0.83 HCRTR2 (0.50) HDAC8NPSR1HDAC3HDAC11HDAC6
SCHEMBL4906992 0.83 ESR1 (0.44) HDAC8NPSR1HDAC3HDAC11HDAC6
SCHEMBL4900544 0.83 KDM4E (0.41) HDAC8NPSR1HDAC3HDAC11HDAC6
SCHEMBL4903873 0.83 HDAC8 (0.38) HDAC8NPSR1HDAC3HDAC11HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD HDAC8 882/4885NPSR1 735/4885HDAC3 157/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD HDAC8 882/4885NPSR1 735/4885HDAC3 157/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.